dilazep and mizoribine

dilazep has been researched along with mizoribine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashimoto, K; Hosoya, M; Kanno, S; Kawasaki, Y; Miyazaki, K; Ono, A; Sato, M; Suyama, K; Suzuki, Y1
Hosoya, M; Kawasaki, Y; Maeda, R; Ohara, S; Suyama, K1

Other Studies

2 other study(ies) available for dilazep and mizoribine

ArticleYear
Resistance factors for the treatment of immunoglobulin A nephropathy with diffuse mesangial proliferation.
    Nephrology (Carlton, Vic.), 2014, Volume: 19, Issue:7

    Topics: Age of Onset; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biopsy; Calgranulin A; Calgranulin B; Child; Dilazep; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunosuppressive Agents; Japan; Kidney Function Tests; Male; Mesangial Cells; Prednisolone; Retrospective Studies; Ribonucleosides; Risk Factors; Severity of Illness Index; Vasodilator Agents

2014
Serum IgA/C3 and glomerular C3 staining predict severity of IgA nephropathy.
    Pediatrics international : official journal of the Japan Pediatric Society, 2018, Volume: 60, Issue:2

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Biopsy; Child; Complement C3; Dilazep; Female; Glomerulonephritis, IGA; Glucocorticoids; Humans; Immunoglobulin A; Kidney Function Tests; Kidney Glomerulus; Male; Prednisolone; Prognosis; Retrospective Studies; Ribonucleosides; Vasodilator Agents; Warfarin

2018